Dementia-Specific assisted living: Clinical factors and psychotropic medication use

Journal of the American Psychiatric Nurses Association

Volumn 14, Issue 1, 2008, Pages 39-49

  Smith, Marianne ^a   Buckwalter, Kathleen C ^a   Kang, Hyunwook ^a   Ellingrod, Vicki ^b   Schultz, Susan K ^c  

^a UNIVERSITY OF IOWA COLLEGE OF NURSING   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Assisted living; Behavioral symptoms; Dementia; Psychotropic mediation

Indexed keywords

EID: 39449113288     PISSN: 10783903     EISSN: 15325725     Source Type: Journal    
DOI: 10.1177/1078390307310692     Document Type: Article

References (41)

1. Alexopoulos, G.S., Abrams, R.C., Young, R.C., & Shamoian, C.A. (1988 a). Cornell Scale for Depression in Dementia. Biological Psychiatry, 23 (3), 271 - 284.
2. Alexopoulos, G.S., Abrams, R.C., Young, R.C., & Shamoian, C.A. (1988 b). Use of the Cornell scale in nondemented patients. Journal of the American Geriatrics Society, 36 (3), 230-236.
3. Anthony, J.C., LeResche, L., Niaz, V., von Kroff, M.R., & Folstein, M.F. (1982). Limits of the "Mini-Mental State" as a screening test for dementia and delirium among hospital patients. Psychiatric Medicine, 12, 397 - 408.
4. Assisted Living Federation of America (ALFA). (2007). Frequently asked questions about assisted living Retrieved May 5, 2007, from http://www.alfa.org
5. Ballard, C., Bannister, C., Solis, M., Oyebode, G., & Wilcock, G. (1996). The prevalence, associations and symptoms of depression amongst dementia suffers. Journal of Affective Disorders, 36, 135-144.
6. Boustani, M., Zimmerman, S., Williams, C.S., Gruber-Baldini, A.L., Watson, L., Reed, P.S., et al. (2005). Characteristics associated with behavioral symptoms related to dementia in long-term care residents The Gerontologist, 45 (Special Issue 1), 56 - 61.
7. Callahan, C.M., Boustani, M., Unverzagt, F., Austrom, M.G., Damush, T.M., Perkins, A.J., et al. (2005). Effectiveness of collaborative care for older adults with Alzheimer's disease in primary care: A randomized controlled trial. Journal of the American Medical Association, 295 (18), 2148-2157.
8. Fankhauser, M.P., & German, M.L. (1987). Understanding the use of behavioral rating scales in studies evaluating the efficacy of antianxiety and antidepressant drugs. American Journal of Hospital Pharmacy, 44, 2087 - 2100.
9. Ferretti, L., McCurry, S.M., Logsdon, R., Gibbons, L., & Teri, L. (2001). Anxiety and Alzheimer's disease. Journal of Geriatric Psychiatry & Neurology, 14 (1), 52 - 58.
10. Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). " Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189 - 198.
11. Food and Drug Administration (FDA). (2005, April 11). FDA public health advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances Retrieved July 2, 2007, from http://www.fda.gov/cder/drug/ advisory/antipsychotics.htm
12. Gruber-Baldini, A.L., Boustani, M., Sloane, P.D., & Zimmerman, S. (2004). Behavioral symptoms in residential care/assisted living facilities: Prevalence, risk factors, and medication management. Journal of the American Geriatrics Society, 52 (10), 1610 - 1617.
13. Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
14. Haupt, M., Kurz, A., & Janner, M. (2000). A 2-year follow-up of behavioural and psychological symptoms in Alzheimer's disease. Dementia & Geriatric Cognitive Disorders, 11 (3), 147 - 152.
15. Hyde, J. (2004, November). Health care in assisted living: Possibilities and realities. Paper presented at the Assisted Living Special Interest Group Pre-Conference, The Gerontological Society of America 57th Annual Scientific Meeting, Washington, DC.
16. Iowa Administrative Code. (2004). Chapter 25 Assisted Living Programs. 321 - 25. 2 (231C) Definitions.
17. Lakey, S.L., Gray, S.L., Sales, A.E.B., Sullivan, J., & Hedrick, S.C. (2006). Psychotropic use in community residential care facilities: A prospective study. The American Journal of Geriatric Pharmacotherapy, 4 (3), 227-235.
18. Lecrubier, Y. (2001). The burden of depression and anxiety in general medicine. Journal of Clinical Psychiatry, 8, 4-9.
19. Lenze, E.J., Mulsant, B.H., Shear, M.K., Alexopoulos, G.S., Frank, E., & Reynolds, C.F., 3rd. (2001). Comorbidity of depression and anxiety disorders in later life Depression & Anxiety, 14 (2), 86 - 93.
20. Mega, M.S., Cummings, J.L., Fiorello, T., & Gornbein, J. (1996). The spectrum of behavioral changes in Alzheimer's disease. Neurology, 46 (1), 130-135.
21. Microsoft Office. (2007). Microsoft Office Official Site Retrieved May 31, 2007, from www.Office2007.com
22. Movig, K.L., Leufkens, H.G., Lenderink, A.W., & Egberts, A.C. (2002). Sertonertic antidepressants associated with increased risk for hyponatremia in the elderly. European Journal of Clinical Pharmacology, 58, 143 - 148.
23. National Center for Assisted Living (NCAL). (2007). Assisted living state regulatory review. Washington, DC: National Center for Assisted Living.
24. Orrell, M., & Bebbington, P. (1996). Psychosocial stress and anxiety in senile dementia. Journal of Affective Disorders, 39 (3), 165-173.
25. Ownby, R.L., Harwood, D.G., Barker, W.W., & Duara, R. (2000). Predictors of anxiety in patients with Alzheimer's disease. Depression & Anxiety, 11 (1), 38 - 42.
26. Reisberg, B., Ferris, S., de Leon, M., & Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136-1139.
27. Rosenblatt, A., & Lyketsos, C.G. (2007). Dementia in assisted living: A multi-component intervention. Baltimore, MD: Johns Hopkins University, School of Medicine, Department of Psychiatry.
28. Rosenblatt, A., Samus, Q., Steele, C., Baker, A., Harper, M.G., Brandt, J., et al. (2004). The Maryland Assisted Living Study: Prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted living population of central Maryland. Journal of the American Geriatrics Society, 52 (10), 1618-1625.
29. Schneider, L.S., Dagerman, K.S., & Insel, P.S. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association, 19 (15), 1934-1943.
30. Schneider, L.S., Dagerman, K.S., & Insel, P.S. (2006). Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14 (3), 191-210.
31. Schulz, R. (Ed.). (2005). Dementia care and quality of life in assisted living and nursing homes. The Gerontologist, 45 (Special Issue 1).
32. Shankar, K.K., Walker, M., Frost, D., & Orrell, M. (1999). The development of a valid and reliable scale for rating anxiety in dementia (RAID). Aging & Mental Health, 3 (1), 39 - 49.
33. Sink, K.M., Holden, K.F., & Yaffe, K. (2006). Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. Journal of the American Medical Association, 293 (5), 596-608.
34. Sloane, P.D., Zimmerman, S., & Ory, M.G. (2001). Care for persons with dementia. In S. Zimmerman, P. D. Sloane, & J. K. Eckert (Eds.), Assisted living: Needs, practices, and policies in residential care for the elderly (pp. 242-270). Baltimore, MD: Johns Hopkins University Press.
35. Smith, M., Buckwalter, K., Kang, H., Schultz, S.K., & Ellingrod, V. (In press a). Dementia care in assisted living: Needs and challenges. Issues in Mental Health Nursing.
36. Smith, M., Buckwalter, K., Kang, H., Schultz, S.K., & Ellingrod, V.L. (In press b). Tales from the field, or: What the nursing research textbooks won't tell you Applied Nursing Research.
37. Steffens, D.C. (2005). Mild cognitive impairment and psychiatric disorders. Paper presented at MCI and Other Non-Dementia Cognitive Conditions: Relevance to Clinical Practice, Chicago, IL.
38. Steffens, D.C., & McQuoid, D.R. (2005). Impact of symptoms of generalized anxiety disorder on the course of late-life depression. American Journal of Geriatric Psychiatry, 13 (1), 40-47.
39. Teri, L., Ferretti, L.E., Gibbons, L.E., Logsdon, R.G., McCurry, S.M., Kukull, W.A., et al. (1999). Anxiety in Alzheimer's disease: Prevalence, and comorbidity. Journal of Gerontology: Medical Sciences, 54A (7), M348- M352.
40. Voyer, P., Verreault, R., Mengue, P.N., Laurin, D., Rochette, L., & Martin, L.S. (2002). Managing disruptive behaviors with neuroleptics: Treatment options for older adults in nursing homes. Journal of Gerontological Nursing, 31 (11), 49-59.
41. Wulf, J. (2006). Preliminary data from a national survey of assisted living centers. Paper presented at the Iowa Department of Elder Affairs Commission Meeting. Des Moines, Iowa.